NO20043841L - 1-Phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for the preparation of drugs used in the treatment of immunological diseases - Google Patents
1-Phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for the preparation of drugs used in the treatment of immunological diseasesInfo
- Publication number
- NO20043841L NO20043841L NO20043841A NO20043841A NO20043841L NO 20043841 L NO20043841 L NO 20043841L NO 20043841 A NO20043841 A NO 20043841A NO 20043841 A NO20043841 A NO 20043841A NO 20043841 L NO20043841 L NO 20043841L
- Authority
- NO
- Norway
- Prior art keywords
- benzimidazole derivatives
- preparation
- treatment
- heteroaryl
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
Det beskrives nye benzimidazolderivater, deres fremstilling og deres anvendelse for fremstilling av legemidler for behandling og forebygging av sykdommer som er assosiert med en mikroglieaktivering, og av T-celle-formidlede immunologiske sykdommer, samt farmasøytiske preparater som inneholder de nye benzimidazolderivater.New benzimidazole derivatives are described, their preparation and their use in the manufacture of medicaments for the treatment and prevention of diseases associated with a microglial activation, and of T-cell mediated immunological diseases, as well as pharmaceutical preparations containing the new benzimidazole derivatives.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10207844A DE10207844A1 (en) | 2002-02-15 | 2002-02-15 | 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use for the preparation of medicaments and pharmaceutical preparations containing these derivatives |
PCT/EP2003/000462 WO2003068766A1 (en) | 2002-02-15 | 2003-01-17 | 1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, the use thereof for producing drugs used in the treatment of immunological diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20043841L true NO20043841L (en) | 2004-11-12 |
NO329667B1 NO329667B1 (en) | 2010-11-29 |
Family
ID=27674913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20043841A NO329667B1 (en) | 2002-02-15 | 2004-09-14 | 1-Phenyl-2- (pyridyl or thienyl) -substituted benzimidazole derivatives, pharmaceutical compositions containing the compounds and their use in the manufacture of drugs used for the treatment of immunological diseases |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP1474415B1 (en) |
JP (1) | JP4739675B2 (en) |
KR (1) | KR101027556B1 (en) |
CN (1) | CN1317274C (en) |
AR (1) | AR038492A1 (en) |
AT (1) | ATE517881T1 (en) |
AU (1) | AU2003205624B2 (en) |
BR (1) | BR0307723A (en) |
CA (1) | CA2475780C (en) |
CR (1) | CR7442A (en) |
CY (1) | CY1113230T1 (en) |
DE (1) | DE10207844A1 (en) |
DK (1) | DK1474415T3 (en) |
EC (1) | ECSP045296A (en) |
ES (1) | ES2369662T3 (en) |
IL (1) | IL163431A (en) |
MX (1) | MXPA04007949A (en) |
NO (1) | NO329667B1 (en) |
NZ (1) | NZ534660A (en) |
PE (1) | PE20030941A1 (en) |
PL (1) | PL216233B1 (en) |
PT (1) | PT1474415E (en) |
RS (1) | RS51831B (en) |
RU (1) | RU2325384C2 (en) |
SI (1) | SI1474415T1 (en) |
TW (1) | TWI328583B (en) |
UA (1) | UA81243C2 (en) |
UY (1) | UY27661A1 (en) |
WO (1) | WO2003068766A1 (en) |
ZA (1) | ZA200407381B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003080580A2 (en) | 2002-03-27 | 2003-10-02 | Glaxo Group Limited | Quinoline derivatives and their use as 5-ht6 ligands |
US7060697B2 (en) * | 2003-05-19 | 2006-06-13 | Irm Llc | Immunosuppressant compounds and compositions |
WO2014044611A1 (en) | 2012-09-20 | 2014-03-27 | Bayer Pharma Aktiengesellschaft | 1-aryl-2-heteroaryl benzimidazoles for the induction of neuronal regeneration |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4330959A1 (en) * | 1993-09-09 | 1995-03-16 | Schering Ag | New benzimidazole derivatives, processes for their preparation and their pharmaceutical use |
US7115645B2 (en) * | 2000-01-14 | 2006-10-03 | Schering Aktiengesellschaft | 1,2 diarylbenzimidazoles and their pharmaceutical use |
BR0107628A (en) * | 2000-01-14 | 2002-10-08 | Schering Ag | 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation |
DE10207843A1 (en) * | 2002-02-15 | 2003-09-04 | Schering Ag | Microlia inhibitors for interruption of interleukin 12 and IFN-gamma mediated immune responses |
-
2002
- 2002-02-15 DE DE10207844A patent/DE10207844A1/en not_active Ceased
-
2003
- 2003-01-17 DK DK03702464.3T patent/DK1474415T3/en active
- 2003-01-17 PL PL371269A patent/PL216233B1/en unknown
- 2003-01-17 RS YU71404A patent/RS51831B/en unknown
- 2003-01-17 RU RU2004127678/04A patent/RU2325384C2/en not_active IP Right Cessation
- 2003-01-17 BR BR0307723-3A patent/BR0307723A/en not_active IP Right Cessation
- 2003-01-17 AU AU2003205624A patent/AU2003205624B2/en not_active Ceased
- 2003-01-17 UA UA20040907405A patent/UA81243C2/en unknown
- 2003-01-17 NZ NZ534660A patent/NZ534660A/en not_active IP Right Cessation
- 2003-01-17 PT PT03702464T patent/PT1474415E/en unknown
- 2003-01-17 CA CA2475780A patent/CA2475780C/en not_active Expired - Fee Related
- 2003-01-17 EP EP03702464A patent/EP1474415B1/en not_active Expired - Lifetime
- 2003-01-17 JP JP2003567893A patent/JP4739675B2/en not_active Expired - Fee Related
- 2003-01-17 MX MXPA04007949A patent/MXPA04007949A/en active IP Right Grant
- 2003-01-17 AT AT03702464T patent/ATE517881T1/en active
- 2003-01-17 SI SI200332061T patent/SI1474415T1/en unknown
- 2003-01-17 WO PCT/EP2003/000462 patent/WO2003068766A1/en active Application Filing
- 2003-01-17 KR KR1020047012576A patent/KR101027556B1/en not_active IP Right Cessation
- 2003-01-17 ES ES03702464T patent/ES2369662T3/en not_active Expired - Lifetime
- 2003-01-17 CN CNB038039974A patent/CN1317274C/en not_active Expired - Fee Related
- 2003-01-31 PE PE2003000110A patent/PE20030941A1/en not_active Application Discontinuation
- 2003-02-11 UY UY27661A patent/UY27661A1/en not_active Application Discontinuation
- 2003-02-12 AR ARP030100437A patent/AR038492A1/en not_active Application Discontinuation
- 2003-02-14 TW TW092103073A patent/TWI328583B/en not_active IP Right Cessation
-
2004
- 2004-08-10 IL IL163431A patent/IL163431A/en not_active IP Right Cessation
- 2004-09-01 CR CR7442A patent/CR7442A/en not_active Application Discontinuation
- 2004-09-14 NO NO20043841A patent/NO329667B1/en not_active IP Right Cessation
- 2004-09-14 ZA ZA2004/07381A patent/ZA200407381B/en unknown
- 2004-09-14 EC EC2004005296A patent/ECSP045296A/en unknown
-
2011
- 2011-10-26 CY CY20111101016T patent/CY1113230T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065878L (en) | Therapeutic compounds | |
DE602004017194D1 (en) | PYRIDYLPYRROL DERIVATIVES AS ACTIVE KINASE INHIBITORS | |
DK1636236T3 (en) | Pyrazolo-quinazoline derivatives, a process for their preparation, and their use as kinase inhibitors | |
NO20052761L (en) | Spirocyclic cyclohexane derivatives. | |
NO20051966L (en) | New pyrimidinamide derivatives and their use | |
NO20080164L (en) | N- (pyridin-2-yl) -sulfonamidderivater | |
AR033423A1 (en) | PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES | |
CO5011096A1 (en) | MEDICINES CONTAINING ANTAGONISTS OF THE 5-HT3 RECEPTOR FOR THE TREATMENT OF IBS | |
NO20062504L (en) | Compositions and dosage forms for improved absorption | |
HUP0402217A2 (en) | Platinum derivative pharmaceutical formulations | |
WO2004000209A3 (en) | Administration of therapeutic viruses | |
NO20055173L (en) | Pharmaceutical combination combination comprising modafinil and another drug | |
AR034213A1 (en) | COMPOSITIONS OF DRUGS ON THE BASE OF ANTI-POLINERGIC AGENTS AND INHIBITORS OF PDE-IV | |
NO20055891L (en) | Quinazoline derivatives as aurorakinase inhibitors | |
CY1106430T1 (en) | MEDICATIONS FOR INHALATION CONTAINING VITAMINS AND AN ANTICHOLINEPG | |
BRPI0508485A (en) | pentafluorsulfanyl compounds, their manufacture and use as pharmaceutical agents | |
UY27455A1 (en) | DERIVATIVES N- (1,4,5,6-TETRAHIDRO-CICLOPENTAPIRAZOL -3-IL) - REPLACED. ITS OBTAINING AND USE AS DRUGS. | |
HK1068606A1 (en) | Novel aminobenzoephenones | |
SE0101932D0 (en) | Pharmaceutical combinations | |
BR0107628A (en) | 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation | |
YU84503A (en) | Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases | |
CY1109001T1 (en) | Kappa-like Fighters in the Treatment of Cystic Diseases | |
ES2191449T3 (en) | DERIVATIVES OF CICLOPENTABENZOFURANO AND ITS USE. | |
NO323466B1 (en) | New quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives, processes for their preparation, use thereof in medicaments for the treatment of pain, and pharmaceutical compositions comprising such derivatives | |
WO2005010022A3 (en) | Agonist polypeptide of receptor for zot and zonulin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE |
|
MM1K | Lapsed by not paying the annual fees |